Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis pigmentosa (XLRP).

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the ...

ITM Radiopharma’s Phase III trial of its targeted radiotherapeutic for patients with Grade 1 or 2 gastroenteropancreatic ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...